As with other pharma companies, much rides on Pfizer's pipeline; it has many promising formulations in late-stage trials.

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Pfizer shares have gained ground since a report over the weekend said that activist investor ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. On April 13, UBS Group AG raised its ...

Pfizer Inc. (NYSE:PFE) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9, 2026, BofA lowered the price target on Pfizer Inc. (NYSE:PFE) to $26 from $27 and maintained a Neutral rating.

View Pfizer Inc. PFE stock quote prices, financial information, real-time forecasts, and company news from CNN.

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Pfizer, with a price target of $35.00. The company’s shares closed yesterday at $26.53. Toung covers the ...

Pfizer (NYSE:PFE | PFE Price Prediction) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at ...

Pfizer (NYSE:PFE) has entered a new alliance with Sarah Cannon Research Institute to accelerate oncology clinical trials and ...

With short-term rates still elevated, tariff uncertainty churning through earnings models, and credit spreads widening at the ...

ICICI Direct maintained a 'Buy' rating with a target price of Rs 5,750. The firm highlighted that revenues grew, driven by established power brands such as Eliquis, Magnex, and Meronem. For Q3 FY26, ...

Pfizer Inc. PFE will release earnings for its third quarter before the opening bell on Tuesday, May 5. Analysts expect the pharmaceutical company to report quarterly earnings of 72 cents per share.

Pfizer and its partners have granted Rigel Pharmaceuticals an exclusive license to commercialize VEPPANU (vepdegestrant), the ...